The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors
Open accessAbstract
Elite suppressors (ES) are untreated human immunodeficiency virus type 1 (HIV-1)-infected individuals who control viremia to levels below the limit of detection of current assays. The mechanisms involved in this control have not been fully elucidated. Several studies have demonstrated that some ES are infected with defective viruses, but it remains unclear whether others are infected with replication-competent HIV-1. To answer this question, we used a sensitive coculture assay in an attempt to isolate replication-competent virus from a cohort of 10 ES. We successfully cultured six replication-competent isolates from 4 of the 10 ES. The frequency of latently infected cells in these patients was more than a log lower than that seen in patients on highly active antiretroviral therapy with undetectable viral loads. Full-length sequencing of all six isolates revealed no large deletions in any of the genes. A few mutations and small insertions and deletions were found in some isolates, but phenotypic analysis of the affected genes suggested that their function remained intact. Furthermore, all six isolates replicated as well as standard laboratory strains in vitro. The results suggest that some ES are infected with HIV-1 isolates that are fully replication competent and that long-term immunologic control of replication-competent HIV-1 is possible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Self-citationIsolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186 · cited 1×
“Using a sensitive coculture assay, we and others have been able to isolate replication-competent virus from patients on HAART who have suppression of viremia to below the limit of detection (12, 17, 18, 52, 53, 55).”
MethodFinzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Self-citationQuantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050 · cited 2×
“Using a sensitive coculture assay, we and others have been able to isolate replication-competent virus from patients on HAART who have suppression of viremia to below the limit of detection (12, 17, 18, 52, 53, 55).”
MethodSelf-citationVigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Self-citationBroad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A., Chatfield, C., et al. (1995) · Science · doi:10.1126/science.270.5238.988 · Cited by 1,155
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
Cao, Y., Qin, L., Zhang, L., Safrit, J., & Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320401 · Cited by 1,037
Migueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005
Absence of Intact nef Sequences in a Long-Term Survivor with Nonprogressive HIV-1 Infection
Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., & Desrosiers, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320405 · Cited by 1,003
Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Kaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-405 · Cited by 970
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
Stopak, K., de Noronha, C., Yonemoto, W., & Greene, W. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00353-8 · Cited by 732
Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection
Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O. J., Demarest, J. F., Montefiori, D., Orenstein, J. M., Fox, C., Schrager, L. K., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320402 · Cited by 730
Betts, M. R., Ambrozak, D. R., Douek, D. C., Bonhoeffer, S., Brenchley, J. M., Casazza, J. P., Koup, R. A., & Picker, L. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.11983-11991.2001 · Cited by 689
Addo, M. M., Yu, X. G., Rathod, A., Cohen, D., Eldridge, R. L., Strick, D., Johnston, M. N., Corcoran, C., Wurcel, A. G., Fitzpatrick, C. A., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2081-2092.2003 · Cited by 669
Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding
O'Doherty, U., Swiggard, W. J., & Malim, M. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10074-10080.2000 · Cited by 664
Hypermutation of HIV-1 DNA in the Absence of the Vif Protein
Lecossier, D., Bouchonnet, F., Clavel, F., & Hance, A. J. (2003) · Science · doi:10.1126/science.1083338 · Cited by 651
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Yu, Q., König, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 597
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 446
Learmont, J. C., Geczy, A. F., Mills, J., Ashton, L. J., Raynes-Greenow, C. H., Garsia, R. J., Dyer, W. B., McIntyre, L., Oelrichs, R. B., Rhodes, D. I., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402203 · Cited by 329
Pilgrim, A. K., Pantaleo, G., Cohen, O. J., Fink, L. M., Zhou, J. Y., Zhou, J. T., Bolognesi, D. P., Fauci, A. S., & Montefiori, D. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/516508 · Cited by 326
Bailey, J. R., Williams, T. M., Siliciano, R. F., & Blankson, J. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052319 · Cited by 283
Self-citationSiliciano, J. D., & Siliciano, R. F. (2005) · Human Retrovirus Protocols · doi:10.1385/1-59259-907-9:003 · Cited by 242
Self-citationMariani, R., Kirchhoff, F., Greenough, T. C., Sullivan, J. L., Desrosiers, R. C., & Skowronski, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7752-7764.1996 · Cited by 218
CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex
Pomerantz, J. L., Denny, E. M., & Baltimore, D. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf505 · Cited by 211
Lum, J. J., Cohen, O. J., Nie, Z., Weaver, J. G., Gomez, T. S., Yao, X.-J., Lynch, D., Pilon, A. A., Hawley, N., Kim, J. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16233 · Cited by 203
Huang, Y., Zhang, L., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.93-100.1995 · Cited by 190
Zhang, H., Zhou, Y., Alcock, C., Kiefer, T., Monie, D., Siliciano, J., Li, Q., Pham, P., Cofrancesco, J., Persaud, D., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1718-1729.2004 · Cited by 180
Self-citationBailey, J. R., Lassen, K. G., Yang, H.-C., Quinn, T. C., Ray, S. C., Blankson, J. N., & Siliciano, R. F. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4758-4770.2006 · Cited by 172
Self-citationHIV Quasispecies and Resampling
Liu, S.-L., Rodrigo, A. G., Shankarappa, R., Learn, G. H., Hsu, L., Davidov, O., Zhao, L. P., & Mullins, J. I. (1996) · Science · doi:10.1126/science.273.5274.415 · Cited by 170
Alexander, L., Weiskopf, E., Greenough, T. C., Gaddis, N. C., Auerbach, M. R., Malim, M. H., O'Brien, S. J., Walker, B. D., Sullivan, J. L., & Desrosiers, R. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4361-4376.2000 · Cited by 162
Migueles, S. A., Laborico, A. C., Imamichi, H., Shupert, W. L., Royce, C., McLaughlin, M. E., Ehler, L. A., Metcalf, J. A., Liu, S., Hallahan, C. W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6889-6898.2003 · Cited by 157
Deeks, S. G., Schweighardt, B., Wrin, T., Galovich, J., Hoh, R., Sinclair, E., Hunt, P. W., McCune, J. M., Martin, J. N., Petropoulos, C. J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00093-06 · Cited by 155
Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease
McNeil, A. J., YAP, P. L., Gore, S. M., Brettle, R. P., McColl, M. D., Wyld, R., Davidson, S., Weightman, R., Richardson, A. M., & Robertson, J. R. (1996) · QJM · doi:10.1093/qjmed/89.3.177 · Cited by 152
Michael, N. L., Chang, G. A. L., d'Arcy, L. A., Ehrenberg, P. K., Mariani, R., Busch, M. P., Birx, D. L., & Schwartz, D. H. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4228-4236.1995 · Cited by 126
Iversen, A. K. N., Shpaer, E. G., Rodrigo, A. G., Hirsch, M., Walker, B. D., Sheppard, H. W., Merigan, T. C., & Mullins, J. I. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5743-5753.1995 · Cited by 99
Michael, N. L., d'Arcy, L. A., Ehrenberg, P. K., & Redfield, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3163-3174.1994 · Cited by 73
Yamada, T., & Iwamoto, A. (2000) · Archives of Virology · doi:10.1007/s007050050692 · Cited by 60
Brettle, R. P., McNeil, A. J., Burns, S. M., Gore, S. M., Bird, A. G., YAP, P. L., MacCallum, L., Leen, C. L. S., & Richardson, A. M. (1996) · AIDS · doi:10.1097/00002030-199604000-00011 · Cited by 56
Huang, Y., Zhang, L., & Ho, D. D. (1998) · Virology · doi:10.1006/viro.1997.8913 · Cited by 56
Huang, Y., Zhang, L., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.8142-8146.1995 · Cited by 55
Monie, D., Simmons, R. P., Nettles, R. E., Kieffer, T. L., Zhou, Y., Zhang, H., Karmon, S. L., Ingersoll, R., Chadwick, K. R., Zhang, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5185-5202.2005 · Cited by 43
Self-citation
Cited by
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Hansen, S. G., Ford, J. C., Lewis, M. S., Ventura, A. B., Hughes, C. M., Coyne-Johnson, L., Whizin, N., Oswald, K., Shoemaker, R., Swanson, T., et al. (2011) · Nature · doi:10.1038/nature10003 · Cited by 988
Deeks, S. G., & Walker, B. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.010 · Cited by 759
Hunt, P. W., Brenchley, J., Sinclair, E., McCune, J. M., Roland, M., Page‐Shafer, K., Hsue, P., Emu, B., Krone, M., Lampiris, H., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/524143 · Cited by 638
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
Persaud, D., Gay, H., Ziemniak, C., Chen, Y. H., Piatak, M., Chun, T.-W., Strain, M., Richman, D., & Luzuriaga, K. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302976 · Cited by 581
Fukazawa, Y., Lum, R., Okoye, A. A., Park, H., Matsuda, K., Bae, J. Y., Hagen, S. I., Shoemaker, R., Deleage, C., Lucero, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3781 · Cited by 477
Metadata
- Authors
- Blankson, J. N., Bailey, J. R., Thayil, S., Yang, H.-C., Lassen, K., Lai, J., Gandhi, S. K., Siliciano, J. D., Williams, T. M., & Siliciano, R. F.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-03
- Volume
- 81
- Issue
- 5
- Pages
- 2508-2518
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2151356086
- Cited by
- 283
- References
- 50
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.